DarrellRW, WagenerHP, KurlandLT. Epidemiology of uveitis. Arch Ophthalmol1962; 68:502.
2.
RothovaA, Suttorp-van SchultenMS, TreffersWF. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol1996; 80(4):332–6.
Bloch-MichelE, NussenblattRB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol1987; 103:234–5.
6.
McCannelCA, HollandGN, HelmCJ. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol1996; 121(1):35–46.
7.
RothovaA, van VeenendaalWG, LinssenA. Clinical features of acute anterior uveitis. Am J Ophthalmol1987; 103:137–45.
8.
Tay-KearneyML, Schwam BL,LowderC. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol1996; 121:47–56.
9.
WeinerA, BenEzraD. Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol1991; 112:151–8.
10.
KanskiJJ. Screening for uveitis in juvenile chronic arthritis. Br J Ophthalmol1989; 73(3):225–8.
11.
GilbertRE, StanfordMR, JacksonH. Incidence of acute symptomatic toxoplasma retinochoroiditis in South London according to country of birth. BMJ1995; 310 (6986):1037–40.
12.
LangdonN, WelshKI, van DamM. Genetic markers in narcolepsy. Lancet1984; 2(8413):1178–80.
13.
International Study Group for Behçet's Disease: Evaluation of diagnostic ('classification') criteria in Behçets disease – towards internationally agreed criteria. Br J Rheumatol1992; 31:299–308.
14.
MishimaS, MasudaK, IzawaY. Behçet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc1979; 76:225–9.
15.
BenEzraD, CohenE. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol1986; 70:589–92.
